Bluebird Botanicals Announces Status as a GMP Compliant Production Facility

Since its inception in 2012, Bluebird Botanicals has always maintained an unwavering commitment to quality and transparency. As such, the company is excited to announce its official status as a good manufacturing practice (GMP) compliant production facility. An audit performed by Eurofins Scientific, a world-leading laboratory testing company, passed Bluebird with an excellent score for compliance to CFR 111 cGMP standards.

A GMP inspection for a dietary supplement is not required by the FDA. However, the team strongly believes in going the extra mile to guarantee the quality of its products. Bluebird Botanicals now stands as one of the only third-party verified, GMP-compliant hemp extract companies in the United States.

Bluebird’s CEO and founder Brandon Beatty said of the development:

"Commitment to excellence is a core ideal at Bluebird. Passing our first 3rd-party GMP audit with a 99% rating is an accomplishment the whole team is very proud of. It's a symbol of the dedication we have to quality, and to our partners and customers."

A GMP inspection includes a thorough review of quality systems, supplier management, the control of raw materials, documentation, calibration, and validation. Detailed processes are standardized for all aspects of workflow and a tight study is conducted of all critical control points for contamination.

Passing the cGMP inspection is largely a testimony to the dedication of Amanda Bowman, the Quality Assurance Manager and Harrington Baker, the Quality Supervisor, who make sure that the immense mountains of paperwork are perfect. Lab managers Luke Brigham, Fionn Masterson, and Dave Sommer were instrumental in implementing the systems that ensured Bluebird Botanicals received an excellent score on their GMP audit.